Combination Therapy of Vertex Cystic Fibrosis Drugs Hits Big Mark

Now watching

Next video starts in : 7 Play

Combination Therapy of Vertex Cystic Fibrosis Drugs Hits Big Mark

Combination Therapy of Vertex Cystic Fibrosis Drugs Hits Big Mark
Replay video
Up next

Jim Cramer Discusses Why He Likes Starwood Hotels and Target

Unlock your personal NFL Now stream by signing in to NFL.com

Combination Therapy of Vertex Cystic Fibrosis Drugs Hits Big Mark

by TheStreet 2:05 mins

Combination Therapy of Vertex Cystic Fibrosis Drugs Hits Big Mark

by TheStreet 2:05 mins

Combination therapy of two Vertex Pharmaceuticals drugs hit a big mark in the treatment of cystic fibrosis. Adam Feuerstein, senior columnist at TheStreet, breaks down the study results of the TRAFFIC and TRANSPORT phase III studies, which when pooled together, resulted in a 3.3% improvement in cystic fibrosis patients' lung function on an absolute basis. Feuerstein reveals whether the results are clinically meaningful and how significant they're likely to be regarded by industry watchers. With the stock soaring pre-market on the news, Feuerstein also explains what the results should mean to shares of Vertex going forward.

TheStreet

Personal Finance

  1. 2:22

    How this woman tracked down her identity thief

  2. 2:23

    3 strategies that can help simplify your life

  3. 2:14

    Would you give your dog your kidney?

  4. 2:14

    5 unique summer jobs that pay great

  5. 1:03

    Money Minute: What employers are really looking for

  6. 2:31

    CEO cashes out to become a farmer

Market Movers